Creutzfeldt-Jakob disease spreads prions throughout the eyes, researchers find

November 20, 2018

Washington, DC - November 20, 2018 - The eyes aren't only a window to the soul; they also offer a new view on rapidly-progressing neurodegenerative disorders called prion diseases.

Researchers recently studied the eyes of 11 people with sporadic Creutzfeldt-Jakob disease (sCJD), the most common and well-known prion disorder. This week in mBio, they report finding prion seeds -- the infectious proteins that cause the disease -- spread throughout the eyes of all the patients.

"It really suggests we could develop a diagnostic, eye-based assay," says pathologist and senior coauthor Christina Sigurdson at the University of California, San Diego. Future eye-based tests, she adds, may be useful to monitor disease progression and evaluate new treatments.

Prions are misfolded proteins that can emerge spontaneously in the brain; in addition, two case studies suggest they can also be transmitted through a prion-contaminated corneal transplant. About 350 people are diagnosed with CJD every year, with symptoms starting around age 60 on average, according to the National Institutes of Health. There's no treatment for CJD or other prion diseases.

When prions aggregate in the brain, they cause neurons to die. Patients with Parkinson's disease and Alzheimer's disease, similarly, are characterized by cognitive decline and an abnormal accumulation of proteins in the brain. Unlike those diseases, however, prion diseases usually accelerate rapidly, and the majority of patients die within a year of diagnosis.

Roughly 40 percent of patients with CJD develop vision or other eye problems. In some patients, vision problems are the first symptom, suggesting that prions begin accumulating in the eye or in the brain areas associated with vision at an early stage.

"We wanted to know how often prions are deposited in the eye, as well as the distribution and levels of prions in the eye," says Sigurdson.

To find out, the researchers analyzed CJD patients' eyes collected by neurologist and senior coauthor Michael Geschwind and his team at the University of California-San Francisco. Multiple eye components were sent to the laboratory of biochemist and study senior coauthor Byron Caughey, at the National Institutes of Health's Rocky Mountain Laboratory in Hamilton, Montana, for measurements using their highly sensitive prion seeding assay (RT-QuIC).

In all 11 patients, they found the highest levels of prion seeds in the retina, the tissue at the back of the eye that receives light from the lens. The assay also detected prions in other parts of the eye, including the cornea, optic nerve, lens, sclera, and muscles that help control eye movement. Previous studies using immunohistochemistry have previously found prions in patients' retinas and optic nerves, but Caughey's assay is the first to find the proteins elsewhere in the eye.

The findings suggest that surgeons who perform corneal transplants or certain eye procedures should exercise caution with their tools, says Sigurdson. "Surgeons could unknowingly contaminate their instruments with prions," she says, noting that single-use instruments may help prevent accidental spread of the disease.

The study also suggests the assay may have applications in other diseases. "If the RT-QuIC method can be used to amplify other aggregated proteins, this might lead to advances in diagnosis for Alzheimer's, Parkinson's and related diseases," says Geschwind.

Sigurdson is currently working on NIH-funded research to label prions in live mice with fluorescent dyes, with an aim toward developing a new diagnostic test. In the future, she says she wants to test the tears of CJD patients for the presence of prions, as well as further investigate the process by which prions move from cell to cell, and from brain to eye.

"Ultimately we would like to develop new treatment strategies to stop prions from spreading," she says.
The American Society for Microbiology is the largest single life science society, composed of more than 30,000 scientists and health professionals. ASM's mission is to promote and advance the microbial sciences.

ASM advances the microbial sciences through conferences, publications, certifications and educational opportunities. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.

American Society for Microbiology

Related Brain Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2
A study by UNC researchers finds that neurodevelopmental scores and gray matter volumes at age two years did not differ between children who had MRI-confirmed asymptomatic subdural hemorrhages when they were neonates, compared to children with no history of subdural hemorrhage.

New model of human brain 'conversations' could inform research on brain disease, cognition
A team of Indiana University neuroscientists has built a new model of human brain networks that sheds light on how the brain functions.

Human brain size gene triggers bigger brain in monkeys
Dresden and Japanese researchers show that a human-specific gene causes a larger neocortex in the common marmoset, a non-human primate.

Unique insight into development of the human brain: Model of the early embryonic brain
Stem cell researchers from the University of Copenhagen have designed a model of an early embryonic brain.

An optical brain-to-brain interface supports information exchange for locomotion control
Chinese researchers established an optical BtBI that supports rapid information transmission for precise locomotion control, thus providing a proof-of-principle demonstration of fast BtBI for real-time behavioral control.

Transplanting human nerve cells into a mouse brain reveals how they wire into brain circuits
A team of researchers led by Pierre Vanderhaeghen and Vincent Bonin (VIB-KU Leuven, Université libre de Bruxelles and NERF) showed how human nerve cells can develop at their own pace, and form highly precise connections with the surrounding mouse brain cells.

Brain scans reveal how the human brain compensates when one hemisphere is removed
Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Alcohol byproduct contributes to brain chemistry changes in specific brain regions
Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome.

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.

Read More: Brain News and Brain Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to